Comparative Study of Distant Metastasis after Quadrantectomy and Modified Radical Mastectomy in Breast Cancer Measuring 40 mm or Less


Abstract in English

Background& Objective: Determining the risk of distant metastasis in invasive breast cancer patients with lesions measuring 40 mm or less, and comparing the risk between quadrantectomy with axillary dissection and modified radical mastectomy with axillary dissection. Materials & Methods: The study was performed prospectively by evaluating a random sample of invasive breast cancer patients with lesions measuring 40 mm or less, who presented to Al-Byroni University Hospital in Damascus during one year between 9/8/2009 and 9/8/2010. Results: Ninety-four breast cancer patients were evaluated. The median age of patients was 54 years. Excisional biopsy was the most common diagnostic tool (41%), and frozen section was used in 27% of patients. The tumor was located in the upper lateral quadrant in 65% of patients. The tumor was in stage one in only 13% of cases, and most tumors were in stage II (63%). Modified radical mastectomy with axillary dissection was performed in 62 patients (66%), and quadrantectomy with axillary dissection was performed in 32 patients (34%). The patients were followed for up to 18 months. Distant metastasis were observed in 8 patients (13%) from the first group and 6 patients (19%) of the second group. Conclusion: There is no important difference of risk of distant metastasis after modified radical mastectomy or quadrantectomy in breast cancer lesions measuring 40 mm or less. We recommend quadrantectomy as the first-line surgical treatment for breast cancer when indicated.

References used

Althuis MD, Dozier JM, Anderson WF, et al. Global trends in breast cancer incidence and mortality 1973– 1997. Int J Epidemiol. 2005;34(2):405–412
(Weir R, Day P, Ali W. Risk factors for breast cancer in women. NZHTA Report 2007;10(2
Touboul E, Buffat L, Belkacémi Y, et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol. 1999;43(1): 25-38
Engela J, Eckela R, Kerra J, et al. The process of metastasisation for breast cancer. Eur J Cancer. 2003; 1794–1806
Solomayer EF, Diel IJ, Meyberg GC, et al. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 2000;59: 271-8

Download